AAPS is co-sponsoring the 2025 Boston Society Gene & Cell Therapy Conference scheduled for March 20-21 at Bristol-Myers Squibb, Cambridge, MA.
Experts will share cutting-edge insights on CMC, regulatory perspectives, bioanalytical assays, emerging cell therapies, and lessons learned from approved cell therapies.
Keynote speakers include Bruce L. Levine, Ph.D., Professor at the Perelman School of Medicine, University of Pennsylvania, and Founding Director of Clinical Cell and Vaccine Production Facility (CVPF), and Kyle Kolaja, Ph.D., DABT Fellow at ATS, and Scientific Vice President at Bristol-Myers Squibb.
Other speakers include Hardik Mody, Ph.D., Genentech; Helen-Marie Dunmore, Certara; Jim McNally, Ph.D., BioAgilytix; Salvatore Iovino, Ph.D., Editas Medicine; Alka Dwivedi, Ph.D., Co-founder of ImmunoACT, and more!
Full speaker lineup and registration information